Brain metastasis responding to gefitinib alone

被引：20

作者：

Poon, ANY

Ho, SSM

Yeo, W

Mok, TSK

机构：

[1] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China

[2] Chinese Univ Hong Kong, Dept Diagnost Imaging, Hong Kong, Hong Kong, Peoples R China

来源：

ONCOLOGY | 2004年 / 67卷 / 02期

关键词：

brain metastases; chemotherapy; lung cancer; metastases; radiotherapy; gefitinib;

D O I：

10.1159/000081005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A woman with stage IIIb non-small cell lung cancer (NSCLC) developed disease progression with brain metastases during chemotherapy. Due to unusual circumstances, the patient received gefitinib alone, without the use of corticosteroid treatment or radiotherapy. There was a dramatic clinical improvement within 1 week. Followup magnetic resonance imaging of the brain 1 month later showed decreases in both the size and number of brain metastases. The patient remains well 9 months after initiation of gefitinib. It is proposed that gefitinib may have a role in treatment of brain metastases from NSCLC. Copyright (C) 2004 S. Karger AG, Basel.

引用

收藏

页码：174 / 178

页数：5

相关论文

共 26 条

[11] Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation: a multicentre phase II study [J].

Korfel, A ;

Oehm, C ;

von Pawel, J ;

Keppler, U ;

Deppermann, M ;

Kaubitsch, S ;

Thiel, E .

EUROPEAN JOURNAL OF CANCER, 2002, 38 (13) :1724-1729

[12] Palliative care [J].

Kvale, PA ;

Simoff, M ;

Prakash, UBS .

CHEST, 2003, 123 (01) :284S-311S

[13] Treatment of relapsed small-cell lung cancer - a focus on the evolving role of topotecan [J].

Lima, CMR ;

Chiappori, A .

LUNG CANCER, 2003, 40 (03) :229-236

[14]

Malacarne P, 1996, ONCOLOGY, V53, P210

[15]

Matsumoto S, 1990, Gan To Kagaku Ryoho, V17, P1933

[16]

Milas L, 2000, CLIN CANCER RES, V6, P701

[17] CIS-DIAMMINEDICHLOROPLATINUM (CDDP) THERAPY FOR BRAIN METASTASIS OF LUNG-CANCER .2. CLINICAL EFFECTS [J].

NAKAGAWA, H ;

FUJITA, T ;

IZUMIMOTO, S ;

MIYAWAKI, Y ;

KUBO, S ;

NAKAJIMA, Y ;

TSURUZONO, K ;

KODAMA, K ;

HIGASHIYAMA, M ;

DOI, O ;

HAYAKAWA, T .

JOURNAL OF NEURO-ONCOLOGY, 1993, 16 (01) :69-76

[18] Concomitant brain radiotherapy and high-dose ifosfamide in brain relapses of lung cancer [J].

Quantin, X ;

Pujol, JL ;

Paris, A ;

RemeSaumon, M ;

Khial, F ;

Godard, P ;

Michel, FB .

ANNALS OF ONCOLOGY, 1997, 8 (09) :911-913

[19] Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer [J].

Quantin, X ;

Khial, F ;

Reme-Saumon, M ;

Michel, FB ;

Pujol, JL .

LUNG CANCER, 1999, 26 (01) :35-39

[20] Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer [J].

Robert, F ;

Ezekiel, MP ;

Spencer, SA ;

Meredith, RF ;

Bonner, JA ;

Khazaeli, MB ;

Saleh, MN ;

Carey, D ;

LoBuglio, AF ;

Wheeler, RH ;

Cooper, MR ;

Waksal, HW .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) :3234-3243